BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1033 related articles for article (PubMed ID: 15976003)

  • 1. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
    J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PGE(2)-EP4 receptor is necessary for stimulation of the renin-angiotensin-aldosterone system in response to low dietary salt intake in vivo.
    Pöschke A; Kern N; Maruyama T; Pavenstädt H; Narumiya S; Jensen BL; Nüsing RM
    Am J Physiol Renal Physiol; 2012 Nov; 303(10):F1435-42. PubMed ID: 22993066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
    Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
    Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of renal prostaglandin receptor mRNAs by dietary salt intake in the rat.
    Jensen BL; Mann B; Skøtt O; Kurtz A
    Kidney Int; 1999 Aug; 56(2):528-37. PubMed ID: 10432392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity.
    Cantone A; Yang X; Yan Q; Giebisch G; Hebert SC; Wang T
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1366-72. PubMed ID: 18385266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of cyclooxygenases and prostanoid receptorsin furosemide-like salt losing tubulopathy: the hyperprostaglandin E syndrome.
    Nüsing RM; Seyberth HW
    Acta Physiol Scand; 2004 Aug; 181(4):523-8. PubMed ID: 15283766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys.
    Schweda F; Klar J; Narumiya S; Nüsing RM; Kurtz A
    Am J Physiol Renal Physiol; 2004 Sep; 287(3):F427-33. PubMed ID: 15113745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
    Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
    J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binary regulation of interleukin (IL)-6 production by EP1 and EP2/EP4 subtypes of PGE2 receptors in IL-1beta-stimulated human gingival fibroblasts.
    Noguchi K; Shitashige M; Endo H; Kondo H; Ishikawa I
    J Periodontal Res; 2002 Feb; 37(1):29-36. PubMed ID: 11842936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome.
    Reinalter SC; Jeck N; Brochhausen C; Watzer B; Nüsing RM; Seyberth HW; Kömhoff M
    Kidney Int; 2002 Jul; 62(1):253-60. PubMed ID: 12081585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 MAP kinase mediates mechanically induced COX-2 and PG EP4 receptor expression in podocytes: implications for the actin cytoskeleton.
    Martineau LC; McVeigh LI; Jasmin BJ; Kennedy CR
    Am J Physiol Renal Physiol; 2004 Apr; 286(4):F693-701. PubMed ID: 14665434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development.
    Abran D; Dumont I; Hardy P; Peri K; Li DY; Molotchnikoff S; Varma DR; Chemtob S
    Circ Res; 1997 Apr; 80(4):463-72. PubMed ID: 9118476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset manifestation of antenatal Bartter syndrome as a result of residual function of the mutated renal Na+-K+-2Cl- co-transporter.
    Pressler CA; Heinzinger J; Jeck N; Waldegger P; Pechmann U; Reinalter S; Konrad M; Beetz R; Seyberth HW; Waldegger S
    J Am Soc Nephrol; 2006 Aug; 17(8):2136-42. PubMed ID: 16807401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin receptors EP2, EP3, and IP mediate exudate formation in carrageenin-induced mouse pleurisy.
    Yuhki K; Ueno A; Naraba H; Kojima F; Ushikubi F; Narumiya S; Oh-ishi S
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1218-24. PubMed ID: 15316088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of PGE2 EP3/EP4 receptors on bladder dysfunction in mice with experimental autoimmune encephalomyelitis.
    Xue R; Jia Z; Kong X; Pi G; Ma S; Yang J
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1656-62. PubMed ID: 24154697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo intra-luteal implants of prostaglandin (PG) E1 or E2 (PGE1, PGE2) prevent luteolysis in cows. II: mRNA for PGF2α, EP1, EP2, EP3 (A-D), EP3A, EP3B, EP3C, EP3D, and EP4 prostanoid receptors in luteal tissue.
    Weems YS; Bridges PJ; Jeoung M; Arreguin-Arevalo JA; Nett TM; Vann RC; Ford SP; Lewis AW; Neuendorff DA; Welsh TH; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2012 Jan; 97(1-2):60-5. PubMed ID: 22120546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.
    Suzawa T; Miyaura C; Inada M; Maruyama T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
    Endocrinology; 2000 Apr; 141(4):1554-9. PubMed ID: 10746663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
    Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M
    Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.
    Jadhav V; Jabre A; Lin SZ; Lee TJ
    J Cereb Blood Flow Metab; 2004 Dec; 24(12):1305-16. PubMed ID: 15625406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
    Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
    Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.